Adverse reactions are rare but occasional allergic reactions including anaphylactoid reactions and urticaria have been reported; pyrexia has occurred after parenteral administration. Seizures and/or syncope have been reported rarely in cancer patients receiving folinate, usually in association with fluoropyrimidine administration and most commonly in those with CNS metastases or other predisposing factors; however, a causal relationship has not been established.